AN1 0.00% 0.8¢ anagenics limited

Ann: Agreement Signed for Sale of Lyramid Limited, page-8

  1. 1,239 Posts.
    lightbulb Created with Sketch. 238
    So the net operational cash flow after 9 months was -$2,106K.
    Take away the 1 off Ikon payment of $1,407K, which leaves -$784K.
    Add back the R&D rebate of $646K makes the net cash outflow -$1,400K.
    Then take away the presumed annual cost reduction of $1,000K or $750K for nine months and net cash outflow is -$650K for nine months, or -$867K annualised.

    On that basis with $8.5M in the bank they wouldn't need a CR for 10 years.

    Last years sales were $7.1M in the 3rd Quarter as opposed to the current $5.1M

    If this years sales were the same we would be $1, 450K cashflow POSITIVE.

    Run your slide rule over that!


 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $3.691M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 1110649 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 615000 4
View Market Depth
Last trade - 10.31am 24/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.